Inspirata Receives 2016 Award for Best Practices in Technology Innovation in the Digital Pathology and Cancer Diagnostics Industry from Frost & Sullivan
Global research organization, Frost & Sullivan, names Inspirata the leader in innovation in the digital pathology and cancer diagnostics arena for its end-to-end pathology workflow solution.
Tampa, FL, December 13, 2016 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. has been recognized by Frost & Sullivan as the innovation leader in the digital pathology and cancer diagnostics arena, having received the research organization’s 2016 Best Practices in Technology Innovation Award.
Inspirata was selected for the award after Frost & Sullivan analysts independently evaluated the company’s technology attributes and future business value. According to analysts’ findings, “Inspirata offers the most complete digital pathology solution in the market today.”
The company’s end-to-end diagnostic workflow solution spans the digitizing of glass slides to create Whole Slide Images (WSIs) that can be viewed and managed by pathologists in a state-of-the-art cockpit. The cockpit also provides single-sign-on access to all of the patient’s institution-based diagnostic data. Having access to all of this information in one place enables pathologists to quickly gain insights about the patient’s history so they can work more efficiently and make better informed decisions leading to a precision diagnosis. The cockpit also features image analytics, a consultation portal, a tumor board module, and has recently been extended to molecular pathology, providing access to cancer genomic data and automating the ordering and receipt of molecular subtyping tests and the associated reports.
In addition to its workflow solution, Inspirata is involved in numerous research and development activities spanning image analysis, prognostic and predictive assays, and a big data analytics initiative focused on cross-referencing cancer signatures in WSIs and -omics data modalities to treatment protocols and patient outcomes.
Frost & Sullivan said it believes Inspirata’s leaders are committed to tapping into the advancements in scientific discovery to bring about relevant changes in medical practice. According to Frost & Sullivan Industry Analyst and Associate Fellow Cecilia Van Cauwenberghe, “Transformational thinking about precision medicine demands multidisciplinary expertise, embracing clinical specialties, scientific research, informatics and big data analytics solutions. Frost & Sullivan sees in Inspirata an unrivaled participant in such a confluence of disciplines and skills.”
“We are honored to receive this award and to have Frost & Sullivan recognize our commitment to developing solutions that transform cancer diagnostics by enabling pathologists to render more precise diagnoses in support of precision medicine,” says Inspirata CEO Satish Sanan.
Download Full Award Write Up Here.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
About Inspirata, Inc.
Inspirata®, Inc. offers the most comprehensive Cancer Diagnostics Workflow Solution available for research and precision diagnosis today. The solution, which employs a unique “solution-as-a-service” delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data repository for clinical, research and educational purposes. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit www.inspirata.com or contact info@inspirata.com.
Source: Inspirata
